The Global Biobased Isobutyric Acid Market was valued at USD 42.7 Million in 2024 and is projected to reach USD 89.1 Million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 8.2% during the forecast period (2024–2032). This robust expansion is being driven by tightening environmental regulations favoring bio-based chemicals, increasing demand for sustainable ingredients across pharmaceuticals and cosmetics, and the accelerating commercialization of advanced fermentation technologies that are making biobased production increasingly competitive with conventional petrochemical methods.

As the global chemicals industry pivots toward low-carbon and renewable alternatives, the spotlight is on the pioneering companies who are driving innovation, scaling production capacity, and forging the supply chain partnerships that will define the next decade of sustainable chemistry. In this blog, we profile the Top 10 Companies in the Biobased Isobutyric Acid Industry—a mix of dedicated biotech innovators, specialty chemical manufacturers, and diversified chemical majors shaping the future of this high-growth market.

---

🕐 1. Afyren

Headquarters: Clermont-Ferrand, France
Key Offering: Fermentation-derived Biobased Isobutyric Acid (≥98% purity), Organic Acid Portfolio

Afyren stands as the undisputed global market leader in biobased isobutyric acid production, having established the world’s first commercial-scale facility dedicated to fermentation-derived organic acids. The company’s proprietary anaerobic fermentation platform utilizes non-food agricultural feedstocks, delivering a genuinely sustainable production model that resonates strongly with pharmaceutical, cosmetic, and food industry buyers. Their €72 million production facility in Carling Saint-Avold, France, which commenced commercial operations, positions Afyren at the frontier of the European bioeconomy transformation.

Sustainability Initiatives:

• Proprietary fermentation technology using lignocellulosic and agricultural co-product feedstocks

• Carbon footprint significantly lower than petrochemical-derived isobutyric acid

• Strategic partnership with Solvay for bio-based polymer applications announced in 2024

Download FREE Sample Report:
Biobased Isobutyric Acid Market – View in Detailed Research Report

---

② 2. Lygos

Headquarters: Berkeley, California, USA
Key Offering: Engineered Microbial Biobased Organic Acids, Isobutyric Acid via Yeast Fermentation

Lygos has emerged as a formidable force in the biobased isobutyric acid space through its differentiated approach to microbial engineering. The company’s proprietary bioengineered yeast platforms have demonstrated yield improvements of 15–20% compared to conventional bacterial fermentation methods, a critical competitive advantage given the raw material cost sensitivities that continue to challenge the broader market. Lygos has further strengthened its commercial position through USDA BioPreferred program certification, opening significant government procurement channels across the United States.

Sustainability Initiatives:

• USDA BioPreferred certified, enabling access to federal government procurement programs

• Continuous fermentation system development aimed at reducing production costs by up to 25%

• Partnerships with downstream chemical manufacturers to secure long-term offtake agreements

---

③ 3. BASF SE

Headquarters: Ludwigshafen, Germany
Key Offering: Pilot-scale Biobased Organic Acids, Bio-based Chemical Intermediates

BASF, the world’s largest chemical company by sales, is actively pursuing its diversification into biobased intermediates, including isobutyric acid, as part of its broader sustainability and portfolio transformation strategy. While BASF currently operates at pilot scale in biobased isobutyric acid production, the company brings unmatched process engineering expertise, global distribution infrastructure, and an established customer base across every major application sector. Industry analysts widely anticipate that BASF’s entry into commercial-scale biobased production will significantly reshape competitive dynamics within the 2025–2030 period.

Sustainability Initiatives:

• Committed to achieving climate neutrality by 2050, with biobased intermediates forming a key pillar of transition

• Significant R&D investment in white biotechnology and bio-based chemical platforms

• Active collaborations with academic institutions on next-generation fermentation biocatalysts

Download FREE Sample Report:
Biobased Isobutyric Acid Market – View in Detailed Research Report

---

④ 4. Dow Chemical Company

Headquarters: Midland, Michigan, USA
Key Offering: Bio-based Chemical Intermediates Portfolio, Renewable Feedstock Derivatives

Dow has been systematically building its bio-based intermediates portfolio as customer demand for sustainable chemistry solutions accelerates across its core end markets. The company’s exploration of biobased isobutyric acid production aligns directly with its stated ambition to source 30% of its addressable feedstock requirements from renewable sources by 2030. Dow’s well-established relationships with pharmaceutical, personal care, and polymer customers provide natural commercialization pathways as its biobased production capabilities mature from pilot to industrial scale.

Sustainability Initiatives:

• Target to reduce absolute carbon emissions by 15% by 2030 versus 2020 baseline

• Investments in bio-refinery partnerships to accelerate renewable feedstock adoption

• Active membership in industry consortia advancing circular economy principles

---

⑤ 5. Mitsubishi Chemical Corporation

Headquarters: Tokyo, Japan
Key Offering: Bio-refinery Chemicals, Biobased Organic Acid Derivatives

Mitsubishi Chemical Corporation is investing in bio-refinery applications as part of its KAITEKI vision for sustainable value creation, with biobased organic acids including isobutyric acid forming part of its renewable chemicals strategy. The company’s strong presence in Asia-Pacific pharmaceutical and plastics markets provides meaningful commercial relevance as biobased isobutyric acid demand grows across these sectors. Mitsubishi Chemical’s established fermentation expertise from adjacent biobased product lines provides a credible technical foundation for expanded isobutyric acid capabilities.

Sustainability Initiatives:

• KAITEKI sustainability framework guiding transition toward bio-based chemical production

• Partnerships with Japanese biotech research institutions on fermentation optimization

• Targeting carbon neutrality across manufacturing operations by 2050

---

⑥ 6. Evonik Industries AG

Headquarters: Essen, Germany
Key Offering: Specialty Biobased Chemicals, Fermentation-derived Organic Acid Intermediates

Evonik Industries brings deep fermentation expertise—developed through its leading amino acid and specialty biochemical businesses—to its growing engagement with biobased carboxylic acid markets. The company’s Health & Nutrition and Smart Materials segments represent natural commercial homes for high-purity biobased isobutyric acid, particularly in pharmaceutical excipient and advanced polymer applications. Evonik’s substantial existing fermentation infrastructure across Germany and the United States provides a competitive advantage in scaling biobased production efficiently.

Sustainability Initiatives:

• Committed to reducing specific greenhouse gas emissions by 50% by 2025 versus 2008 baseline

• Established track record in industrial biotechnology and white fermentation processes

• Active investment in bio-based specialty chemical pipeline through internal R&D and acquisitions

Download FREE Sample Report:
Biobased Isobutyric Acid Market – View in Detailed Research Report

---

⑦ 7. Corbion N.V.

Headquarters: Amsterdam, Netherlands
Key Offering: Biobased Organic Acids, Fermentation-derived Chemical Intermediates

Corbion is a recognized global leader in lactic acid and biobased chemical production, and its fermentation expertise makes it a natural participant in the emerging biobased isobutyric acid space. The company’s established relationships with food, pharmaceutical, and bioplastics customers across North America and Europe provide direct commercial pathways for biobased isobutyric acid as it scales. Corbion’s proven ability to manage complex fermentation supply chains at industrial scale sets it apart from newer market entrants still working through production optimization challenges.

Sustainability Initiatives:

• Science-based targets aligned with Paris Agreement 1.5°C pathway

• All products positioned as renewably sourced from non-food or sustainable food crop feedstocks

• Active participant in EU bioeconomy policy development and industry working groups

---

⑧ 8. Cargill, Incorporated

Headquarters: Wayzata, Minnesota, USA
Key Offering: Fermentation-derived Biobased Chemicals, Agricultural Feedstock-based Organic Acids

Cargill’s vast agricultural supply chain and established fermentation infrastructure position it as a compelling long-term player in the biobased isobutyric acid market. The company’s global network of grain procurement, processing, and distribution assets provides a structural cost advantage in feedstock sourcing that few competitors can match. As Cargill continues to expand its biobased chemical production activities alongside its core food and agriculture operations, its entry into higher-value specialty fermentation markets including isobutyric acid becomes increasingly plausible and commercially attractive.

Sustainability Initiatives:

• Target to achieve net-zero greenhouse gas emissions across global supply chain by 2050

• Investments in regenerative agriculture to improve feedstock sustainability credentials

• Long-term partnerships with biorefinery operators to develop integrated fermentation value chains

---

⑨ 9. Koninklijke DSM N.V. (dsm-firmenich)

Headquarters: Heerlen, Netherlands
Key Offering: Bioscience-derived Specialty Chemicals, Fermentation Ingredients

DSM—now operating as dsm-firmenich following its landmark merger—brings world-class biotechnology capabilities and an extensive portfolio of fermentation-derived specialty chemicals to bear on the biobased isobutyric acid opportunity. The company’s established presence in pharmaceutical ingredients, food nutrition, and personal care markets creates natural demand channels for high-purity biobased isobutyric acid. DSM’s microbial strain development capabilities, honed across decades of vitamin and enzyme production, represent a genuine competitive asset in optimizing isobutyric acid fermentation yields and economics.

Sustainability Initiatives:

• Committed to 50% reduction in greenhouse gas emissions by 2030 versus 2016 baseline

• Pioneering efforts in bio-based ingredient solutions across nutrition and personal care sectors

• Active R&D investment in next-generation biocatalysis and continuous fermentation platforms

---

👑 10. Genomatica, Inc.

Headquarters: San Diego, California, USA
Key Offering: Engineered Microbial Platforms for Biobased Chemicals, Metabolic Engineering Solutions

Genomatica has built a formidable reputation as the leading metabolic engineering platform company enabling biobased production of chemicals that were previously only accessible through petrochemical synthesis. While Genomatica primarily operates through technology licensing rather than direct manufacturing, its engineered microorganism platforms have demonstrated strong applicability to short-chain carboxylic acid production, including isobutyric acid. Several large chemical manufacturers are actively exploring Genomatica-powered production routes for biobased organic acids, positioning the company as a critical enabler of the market’s next phase of commercial scale-up.

Sustainability Initiatives:

• Technology platform enabling up to 100% renewable carbon in chemical production

• Partnerships with global chemical and consumer goods companies to accelerate biobased chemical commercialization

• Recognized leader in synthetic biology applications for industrial sustainability

Get Full Report Here:
Biobased Isobutyric Acid Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Biobased Isobutyric Acid Is Greener and More Competitive

The biobased isobutyric acid market is undergoing a dynamic and accelerating transformation. While petroleum-derived isobutyric acid still accounts for the majority of global supply, the industry is witnessing a structural shift as fermentation technology matures, production economics improve, and regulatory environments across key markets increasingly favor bio-based alternatives over conventional petrochemical feedstocks.

📈 Key Trends Shaping the Market:

• Rapid commercial-scale fermentation capacity expansion in Europe and North America, with Asia-Pacific emerging as the next major growth theater

• Regulatory mandates and corporate sustainability commitments driving formulators in pharmaceuticals, cosmetics, and food toward bio-based ingredient sourcing

• Technological advances in microbial strain engineering and continuous fermentation reducing production cost premiums versus petrochemical alternatives

• Growing pipeline of bioplastics and high-performance polymer applications creating new long-term demand streams for biobased isobutyric acid derivatives

• Strategic M&A activity intensifying as major chemical corporations seek to accelerate market entry through acquisition of leading biotech producers

Get Full Report Here:
Biobased Isobutyric Acid Market – View in Detailed Research Report

The companies profiled above are not only producing a critical chemical intermediate—they’re spearheading the green chemistry revolution that is fundamentally reshaping how the world sources and manufactures the building blocks of modern industry.